Valsartan Tablet shortage
Valsartan Tablet is currently listed in shortage by the FDA. The FDA lists 4 affected products. This page was last refreshed from FDA data on Sep 28, 2026.
Mylan is permanently stopping its valsartan tablets — all strengths (40 mg, 80 mg, 160 mg, and 320 mg) are affected. Diovan (valsartan) tablets in the same strengths are still listed by manufacturers that have not reported a shortage.
Don’t stop or change your therapy on your own — talk with your prescriber about the plan that fits you, and ask your pharmacist what’s actually available (see options).
Do you take this drug? See the ‘What to do’ recommendation from Dr. Brian Staiger, PharmD →What’s in shortage — at a glance
These figures count only the manufacturers that reported this shortage to the FDA — not every company that makes Valsartan Tablet. Other makers that haven’t reported a problem are shown in the green card below.
Shortage timeline
-
Nov 19, 2025Currently in shortage4 of 4 products affected.
-
Nov 19, 2025First reported to the FDA4 products first listed.
Built from FDA posting and update dates. The end date FDA publishes is the posting/update date, not a true resolution date, so durations are approximate.
What exactly is on backorder — by manufacturer
Manufacturer: Mylan Pharmaceuticals Inc., a Viatris Company 📞 800-796-9526 4 NDCS click to expand
| Status | NDC / product | Strength | Availability | Related information | Reason |
|---|---|---|---|---|---|
| To Be Discontinued | Valsartan, Tablet, 40 mg (NDC 0378-5807-93) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Valsartan, Tablet, 80 mg (NDC 0378-5813-77) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Valsartan, Tablet, 160 mg (NDC 0378-5814-77) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
| To Be Discontinued | Valsartan, Tablet, 320 mg (NDC 0378-5815-77) | — | — | A business decision was made to discontinue manufacture of the drug. | — |
These rows are manufacturer reports to the FDA for Valsartan Tablet — they do not necessarily cover every manufacturer that makes this drug. A company appears here only if it told the FDA it has a supply problem, so other makers may still have stock. That’s the basis for the Where else can I get Valsartan Tablet? options further down this page.
Why is Valsartan Tablet in shortage?
Mylan Pharmaceuticals (a Viatris company) has made a business decision to permanently stop making their valsartan tablets across all four strengths — the 40 mg, 80 mg, 160 mg, and 320 mg tablets. No specific public reason beyond it being a business decision was shared with the FDA.
It's worth knowing that this report only covers Mylan's products. Other manufacturers of valsartan tablets are listed separately and are not part of this particular shortage report.
Based on the manufacturer-reported reason(s) and notes on file with the FDA for Valsartan Tablet, summarized in plain English by HelloPharmacist. A drug can be short for more than one reason, and the FDA updates these as manufacturers report changes.
What should I do if I take Valsartan Tablet?
Valsartan tablets are currently on the FDA shortage list. This is a blood pressure medicine, and I want to walk you through what the report shows and your next steps.
The report covers all four strengths — 40 mg, 80 mg, 160 mg, and 320 mg — and none of these have an available source from the manufacturer that filed this record. The reason listed is a business decision to discontinue making the drug. Because this is a discontinuation rather than a temporary delay, this particular supply may not come back. That said, this report reflects only one manufacturer (Mylan/Viatris), and other companies still make valsartan.
Here is how to handle it:
- Do not stop, skip, or change your dose on your own — keeping your blood pressure controlled matters.
- Ask your pharmacy to check wholesalers and other makers. The same medicine, valsartan, is available from other manufacturers, including Novartis (Diovan), Unichem, and Camber — though your pharmacy may need to order it since it might not be in local stock.
- If your exact tablet cannot be found, ask your prescriber or pharmacist about options, such as another maker's version or a clinician-chosen plan.
Manufacturer contact numbers are listed on this page for reference; pharmacies usually handle those calls. This is general, national information and may not match your local pharmacy's stock.
- Don’t stop or change the medication on your own — talk to your prescriber first.
- If this is part of an ongoing or essential regimen (for example HIV treatment or prevention, seizure, heart, transplant, diabetes or mental-health medicines), do not skip or ration doses — contact your pharmacist or prescriber right away to arrange continued supply before you run out.
- Ask your pharmacy to check other manufacturers, strengths, package sizes, and nearby stores.
- Ask your prescriber whether a different strength, formulation, or the brand/generic version is appropriate.
Uses, dosing, side effects, prices, and the complete FDA label — written in plain English and pharmacist-reviewed.
Where else can I get Valsartan Tablet?
FDA shortages are manufacturer-reported — a company only shows up on the shortage list if it told the FDA it has a supply problem, so not every maker of Valsartan Tablet is necessarily short. Below we pull together the other still-marketed options that are not reported in shortage: the same medicine from manufacturers that haven’t reported a problem, and alternative dosage forms. These may still be out of stock at your pharmacy, and only your prescriber or pharmacist can decide what’s right for you.
Same medicine, other manufacturers (not reported short)
Same active ingredient, dosage form & route as the shortage (matched on the FDB HICL ingredient code), from makers that have not filed a shortage with the FDA:
| Product | Strength | Form / route | Manufacturer | NDC |
|---|---|---|---|---|
| Diovan | VALSARTAN 80 mg/1 | Tablet · Oral | Novartis Pharmaceuticals Corporation | 00078-0358-34 |
| Diovan | VALSARTAN 160 mg/1 | Tablet · Oral | Novartis Pharmaceuticals Corporation | 00078-0359-34 |
| Diovan | VALSARTAN 320 mg/1 | Tablet · Oral | Novartis Pharmaceuticals Corporation | 00078-0360-34 |
| Diovan | VALSARTAN 40 mg/1 | Tablet · Oral | Novartis Pharmaceuticals Corporation | 00078-0423-15 |
| Valsartan | VALSARTAN 40 mg/1 | Tablet, Film Coated · Oral | Unichem Pharmaceuticals (USA), Inc. | 29300-0232-10 |
| Valsartan | VALSARTAN 80 mg/1 | Tablet, Film Coated · Oral | Unichem Pharmaceuticals (USA), Inc. | 29300-0233-10 |
| Valsartan | VALSARTAN 160 mg/1 | Tablet, Film Coated · Oral | Unichem Pharmaceuticals (USA), Inc. | 29300-0234-10 |
| Valsartan | VALSARTAN 320 mg/1 | Tablet, Film Coated · Oral | Unichem Pharmaceuticals (USA), Inc. | 29300-0235-10 |
| Valsartan | VALSARTAN 40 mg/1 | Tablet, Film Coated · Oral | Camber Pharmaceuticals, Inc. | 31722-0151-05 |
| Valsartan | VALSARTAN 80 mg/1 | Tablet, Film Coated · Oral | Camber Pharmaceuticals, Inc. | 31722-0152-05 |
| Valsartan | VALSARTAN 160 mg/1 | Tablet, Film Coated · Oral | Camber Pharmaceuticals, Inc. | 31722-0153-05 |
| Valsartan | VALSARTAN 320 mg/1 | Tablet, Film Coated · Oral | Camber Pharmaceuticals, Inc. | 31722-0154-05 |
Alternative dosage forms of Valsartan
A different form of the same drug (for example a solution when capsules are short). A form change is a clinical decision — ask your prescriber:
Therapeutic equivalents & pricing 30 productsclick to expand
Orange Book–rated equivalents of the affected strengths, with the latest NADAC price (a federal retail-acquisition benchmark, not your copay) and an evidence-based availability label. Cheapest first.
| Product | Manufacturer | Package | NADAC $/unit | AB rating | Availability |
|---|---|---|---|---|---|
| Valsartan 80 mg | Mylan | 90 tablets | $0.082 | AB | Availability likely |
| Valsartan 80 mg | Macleods | 90 tablets | $0.082 | AB | Availability likely |
| Valsartan 80 mg | AvPAK | 1 tablet | $0.082 | AB | Availability likely |
| Valsartan 80 mg | American | 1 tablet | $0.082 | AB | Availability likely |
| Valsartan 80 mg | Amneal | 90 tablets | $0.082 | AB | Availability likely |
| Valsartan 80 mg | Viona | 90 tablets | $0.082 | AB | Availability likely |
| Valsartan 80 mg | Archis | 90 tablets | $0.089 | AB | Discontinued |
| Valsartan 40 mg | Mylan | 30 tablets | $0.096 | AB | Availability likely |
| Valsartan 40 mg | Macleods | 30 tablets | $0.096 | AB | Availability likely |
| Valsartan 40 mg | Solco | 30 tablets | $0.096 | AB | Availability likely |
| Valsartan 40 mg | AvPAK | 1 tablet | $0.096 | AB | Availability likely |
| Valsartan 40 mg | American | 1 tablet | $0.096 | AB | Availability likely |
| Valsartan 40 mg | Amneal | 30 tablets | $0.096 | AB | Availability likely |
| Valsartan 40 mg | Viona | 30 tablets | $0.096 | AB | Availability likely |
| Valsartan 40 mg | Archis | 30 tablets | $0.096 | AB | Discontinued |
| Valsartan 160 mg | Mylan | 90 tablets | $0.106 | AB | Availability likely |
| Valsartan 160 mg | Macleods | 90 tablets | $0.106 | AB | Availability likely |
| Valsartan 160 mg | AvPAK | 1 tablet | $0.106 | AB | Availability likely |
| Valsartan 160 mg | American | 1 tablet | $0.106 | AB | Availability likely |
| Valsartan 160 mg | Amneal | 90 tablets | $0.106 | AB | Availability likely |
| Valsartan 160 mg | Viona | 90 tablets | $0.106 | AB | Availability likely |
| Valsartan 160 mg | Archis | 90 tablets | $0.112 | AB | Discontinued |
| Diovan 40 mg | Novartis | 30 tablets | $7.816 | AB | Availability likely |
| Diovan 80 mg | Novartis | 90 tablets | $9.327 | AB | Availability likely |
| Diovan 160 mg | Novartis | 90 tablets | $10.038 | AB | Availability likely |
| Valsartan 40 mg | Unichem | 1000 tablets | — | — | FDA listed |
| Valsartan 40 mg | Camber | 500 tablets | — | AB | FDA listed |
| Valsartan 40 mg | Camber | 500 tablets | — | AB | FDA listed |
| Valsartan 40 mg | AvKARE | 30 tablets | — | AB | FDA listed |
| Valsartan 40 mg | Laurus | 500 tablets | — | AB | FDA listed |
Equivalents share the same ingredient, strength, dosage form and route; an AB rating means the FDA considers them substitutable. NADAC is a national retail-pharmacy acquisition benchmark from CMS — not what you pay. Availability is inferred from recent pricing, not a stock check.
Other drugs in the same treatment class
These are different medicines — not other versions of Valsartan Tablet — that fall in the same broad treatment class (antihypertensives, angiotensin receptor antagonist) . They are not automatic substitutes: they can differ in how they work, dosing, effectiveness, side effects and what they’re approved to treat. Do not switch on your own. This list is for information only — ask your prescriber or pharmacist whether any of them is appropriate for you.
Identity & classification
Where does this data come from?
Other cardiovascular shortages
Valsartan Tablet shortage FAQs
Is Valsartan Tablet in shortage?
Which products are affected?
When will Valsartan Tablet be available again?
Can I still get Valsartan somewhere?
What should I do if I take Valsartan Tablet?
Still have a question about the Valsartan Tablet shortage?
Ask a pharmacist about this shortage →View Valsartan Tablet on the FDA drug-shortage database →
Where does this data come from?
/drug/shortages) — drug, manufacturer & contact, NDC/product, status, availability, reason, therapeutic category and posting/update dates. Current / To Be Discontinued = active; Resolved is kept for history. The Supply-Risk rating is assessed per active ingredient and adds the FDA NDC Directory (still-marketed manufacturers by ingredient & form); same-medicine and equivalent products use First Databank classification + CMS NADAC pricing; Medicaid use + most-affected states come from CMS Medicaid State Drug Utilization Data. Reference only — confirm current status with the manufacturer or FDA before acting on it.